title: Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections.
abstract: BACKGROUND
  Complicated skin and skin-structure infections (cSSSI), including surgical site infections (SSI), cellulitis, and abscesses, have been extensively studied, but controversial issues still exist.
  
  
  OBJECTIVE
  The aim of this GISIG (Gruppo Italiano di Studio sulle Infezioni Gravi) working group - a panel of multidisciplinary experts - was to define recommendations for the following controversial issues: (1) What is the efficacy of topical negative pressure wound treatment as compared to standard of care in the treatment of severe surgical site infections, i.e., deep infections, caused by Gram-positive microorganisms? (2) Which are the most effective antibiotic therapies in the treatment of cSSSI, including SSI, due to methicillin-resistant staphylococci? Results are presented and discussed.
  
  
  METHODS
  A systematic literature search using the MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and www.clinicaltrials.gov databases of randomized controlled trials and/or non-randomized studies was performed. A matrix was created to extract evidence from original studies using the CONSORT method to evaluate randomized clinical trials and the Newcastle-Ottawa Quality Assessment Scale for case-control studies, longitudinal cohorts, and retrospective studies. The GRADE method was used for grading quality of evidence. An analysis of the studies published between 1990 and 2008 is presented and discussed in detail.
authors.affiliation: Divisione di Malattie Infettive e Tropicali, Istituti Ospitalieri di Cremona, Cremona, Italy. angelo.pan1@tin.it
authors.forename: Angelo
authors.initials: A
authors.lastname: Pan
authors.forename: Roberto
authors.initials: R
authors.lastname: Cauda
authors.forename: Ercole
authors.initials: E
authors.lastname: Concia
authors.forename: Silvano
authors.initials: S
authors.lastname: Esposito
authors.forename: Gabriele
authors.initials: G
authors.lastname: Sganga
authors.forename: Stefania
authors.initials: S
authors.lastname: Stefani
authors.forename: Emanuele
authors.initials: E
authors.lastname: Nicastri
authors.forename: Francesco N
authors.initials: FN
authors.lastname: Lauria
authors.forename: Giampiero
authors.initials: G
authors.lastname: Carosi
authors.forename: Mauro
authors.initials: M
authors.lastname: Moroni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Ippolito
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy*; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D008875:Middle Aged; D054843:Negative-Pressure Wound Therapy / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic; D017192:Skin Diseases, Bacterial / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy*; D059039:Standard of Care; D013207:Staphylococcal Skin Infections / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy; D013211:Staphylococcus aureus / Q000187:drug effects; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents